NCT05734521View on ClinicalTrials.gov

Avalglucosidase Alfa Pregnancy Study

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

October 31, 2032

Study Completion Date

October 31, 2032

Conditions
Pompe DiseasePregnancy
Interventions
BIOLOGICAL

avalglucosidase alfa-NGPT (GZ402666) IV

intravenous infusion

BIOLOGICAL

avalglucosidase alfa-NGPT (GZ402666)

exposed via pregnancy and lactation

Trial Locations (1)

08807

RECRUITING

Investigational site worldwide, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY